NCT07558954

Brief Summary

Study Purpose: To develop a pulmonary rehabilitation intervention program suitable for school-age children with asthma, and to evaluate its effectiveness in improving asthma control in children through a prospective randomized controlled trial. Study Methods: This is a single-center, prospective, randomized, open-label, parallel-controlled trial. Eligible subjects who meet all inclusion criteria and none of the exclusion criteria, together with their families, will be randomly assigned in a 1:1 ratio to either the intervention group (family-empowered pulmonary rehabilitation intervention) or the control group (conventional pulmonary rehabilitation care) after signing the informed consent form. Both groups will receive a 12-week core intervention period, with follow-up assessments conducted at baseline, end of intervention (12 weeks), and at 24 and 48 weeks after intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Dec 2027

First Submitted

Initial submission to the registry

February 27, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

April 30, 2026

Status Verified

February 1, 2026

Enrollment Period

1.5 years

First QC Date

February 27, 2026

Last Update Submit

April 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Asthma control level

    Evaluate using the change in the Childhood Asthma Control Test (C-ACT) score. The C-ACT score ranges from 0 to 27, with higher scores indicating better control.

    Baseline

Secondary Outcomes (1)

  • Pulmonary function

    Baseline

Study Arms (2)

Family-empowered pulmonary rehabilitation intervention group

EXPERIMENTAL
Behavioral: Family-empowered pulmonary rehabilitation

Conventional pulmonary rehabilitation care group

OTHER
Behavioral: Conventional pulmonary rehabilitation care

Interventions

Family-empowered pulmonary rehabilitation intervention, including education, skills training, and home-based rehabilitation guidance.

Family-empowered pulmonary rehabilitation intervention group

Routine pulmonary rehabilitation care and regular follow-up as per clinical practice.

Conventional pulmonary rehabilitation care group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • School-aged children aged 6 to 12 years.
  • Meet the diagnostic criteria for asthma according to the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2025 Edition).
  • Received regular inhaled asthma medications for at least 3 months, with moderate or better medication adherence (score ≥6 on the Morisky Medication Adherence Scale).
  • Pulmonary function test shows obstructive ventilatory dysfunction or small airway dysfunction.
  • The primary caregiver has good communication and literacy skills, can use smartphone applications (e.g., WeChat) proficiently, and is willing to participate in the study.
  • Written informed consent has been obtained from the participant and their legal guardian.

You may not qualify if:

  • Children in acute asthma exacerbation.
  • Presence of other severe chronic diseases (e.g., congenital heart disease, neuromuscular disease, immunodeficiency disease, etc.).
  • Children with mental or psychological disorders who cannot cooperate.
  • Other conditions judged by the investigator to be unsuitable for participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2026

First Posted

April 30, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

April 30, 2026

Record last verified: 2026-02